SuperCrowd
Progress update · Form C-U
A progress update — the company is reporting how its raise is going (often that it hit its target).
Aspire BioPharma, Inc.
aspirebiolabs.com · PR · Filed Feb 7, 2024
Aspire BioPharma, Inc. filed a Form C-U — progress update — with the SEC on Feb 7, 2024. The Regulation Crowdfunding offering seeks $150,000, up to a maximum of $5,000,000 on Republic. Investors receive: Preferred Stock at $0.80. The offering closes 01-31-2024.
| Target raise | $150,000 |
|---|---|
| Maximum raise | $5,000,000 |
| Security | Preferred Stock @ $0.80 |
| Closes | 01-31-2024 |
| Portal | Republic |
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.